Head-to-head · free

Tenon Medical, Inc. vs 10x Genomics, Inc.

TNON vs TXG — return on capital, cash generation, margins and balance sheet side by side.

TNON

3 / 9

measures where TNON leads

TXG

6 / 9

measures where TXG leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureTNON · FY2025TXG · FY2025
Revenue$3.9M$642.8M
Net income(12.6M)(43.5M)
Revenue growth (yearly, multi-year)78.7%7.0%
Free cash flow(11.0M)$130.1M
Free cash flow margin-279.4%20.2%
Net cash / (debt)——
ROIC——
Return on equity-600.0%-5.8%
Gross margin59.8%69.1%
Operating margin-324.3%-17.2%
Net debt / EBITDA0.31x27.61x

Figures are as reported by each company; latest fiscal year shown.

Where Tenon Medical, Inc.'s cash went (FY2025)

Capital spending
$273000
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full TNON profile →

Where 10x Genomics, Inc.'s cash went (FY2025)

Capital spending
$5.9M
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full TXG profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons